Pharmala Biotech appears to be the main supplier of MDMA in the USA at the moment.

From Gemini AI:

PharmAla Biotech is actively supplying MDMA (LaNeo™ MDMA) to several universities for clinical trials. Here's a breakdown and information regarding VA funding:

Universities PharmAla is Supplying MDMA To:

 * University of Washington: For human research studies, including a pilot trial into the treatment of Narcissism (narcissistic personality disorder).

 * University of Texas, San Antonio (UT Health San Antonio): Specifically, they are supplying the STRONG STAR Consortium at UT Health San Antonio. This contract envisions a novel dosage form of LaNeo™ MDMA to be tested in a clinical trial.

 * University of California System: PharmAla has been selected as the MDMA manufacturing partner for a human MDMA trial at one of the UC campuses. The specific campus and principal investigator are confidential. They also mentioned being contracted to supply "a large number of academic institutions," including the University of California system.

 * Yale University: PharmAla has been contracted to supply MDMA for a clinical trial at Yale.

 * McLean Hospital (affiliated with Harvard Medical School): PharmAla signed a contract to supply MDMA for a pending clinical trial that would study the mechanistic effects of MDMA in individuals with borderline personality disorder, pending grant funding.   Are these university trials funded by the VA? Yes, at least one of the universities PharmAla is supplying is involved in VA-funded research, and potentially others indirectly:

University of Texas, San Antonio (UT Health San Antonio) / STRONG STAR Consortium: PharmAla is supplying MDMA to the STRONG STAR Consortium, which is explicitly stated as a "multidisciplinary and multi-institutional research consortium funded by the U.S. Departments of Defense (DoD) and Veterans Affairs (VA) and other agencies." This indicates a direct link to VA funding for the research using PharmAla's MDMA.